Venlafaxine Hydrochloride 37.5 mg Capsule, Extended Release
by Zydus Lifesciences Limited · 10 BLISTER PACK in 1 CARTON (70771-1836-4) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70771-1836-2)
NDC 70771-1836-04
🏷️ FDA NDC (as labeled)
70771-1836-4
billing pads the package segment with a zero
This package
Contains10 capsule, extended release in 1 blister pack
Pack sizes5 compare ↓
Also priced by: Part D plans $0.2146/unit — full pricing hub ↓
Also comes in:
30 capsules 70771-1836-03
90 capsules 70771-1836-09
500 capsules 70771-1836-05
1000 capsules 70771-1836-00
Rx only
Generic
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
70771-1836-4
Product NDC
70771-1836
11-digit billing NDC
70771183604
UNII
7D7RX5A8MO
UPC
0370771183890
Application #
ANDA090174
SPL Set ID
1349bace-d2cb-4c8f-8cbd-c09e67a2ca1b
Established class (EPC)
Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of action
Norepinephrine Uptake Inhibitors; Serotonin Uptake Inhibitors
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2023-05-18
Route
ORAL
Dosage form
CAPSULE, EXTENDED RELEASE
Substance
VENLAFAXINE HYDROCHLORIDE
TE code (Orange Book)
AB · RLD · RS
Why two NDCs?
The FDA registers this code as 70771-1836-4 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70771-1836-04. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Serotonin and Norepinephrine Reuptake Inhibitor class.
Pharmacologic class
Serotonin and Norepinephrine Reuptake Inhibitor
Drug family (ATC)
Other antidepressants
How it works
Norepinephrine Uptake Inhibitors, Serotonin Uptake Inhibitors
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerZydus Lifesciences Limited
Application holderZYDUS PHARMACEUTICALS USA INC
FDA applicationANDA090174 (ANDA)
Labeler code70771
First marketedMay 2023
Product typeHuman Prescription Drug
Portfolio717 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📗 Our plain-language guide HelloPharmacist
- Venlafaxine treats major depressive disorder in all its forms. Depending on which formulation you're prescribed, it can also treat generalized anxiety disorder, social anxiety diso...
- Most people don't feel a full benefit right away — it typically takes several weeks before you notice a meaningful improvement in mood or anxiety. Blood levels stabilize within abo...
- How long does it take for venlafaxine to start working?
- The most common side effects are nausea, dry mouth, sweating, drowsiness or insomnia, dizziness, and decreased appetite — and many of these tend to improve after the first couple o...
Patient education
Supplement & herbal interactions
1
Nutrient depletion considerations
Venlafaxine may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Venlafaxine Hydrochloride?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
Gray / White / Pink / Orange
ShapeCapsule
ImprintZA;37;150;mg
Size23 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII H3UP11403C
Ethylcellulose is a plant-derived polymer that thickens and forms protective coatings on tablets and capsules. It slows medicine release into the body and protects the contents from moisture and air.
-
UNII XM0M87F357
A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
-
UNII 2G86QN327L
Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
-
UNII 36SFW2JZ0W
Hypromellose 2910 is a plant-based thickening agent derived from cellulose. In medicines, it forms a protective coating on tablets or capsules and controls how quickly the drug dissolves and releases into your body.
-
UNII R75537T0T4
Hypromellose 2910 is a plant-derived thickening agent made from cellulose. It serves as a binder that holds tablet ingredients together, a film-coating for pills, and a viscosity controller in liquids.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII Q662QK8M3B
Polyethylene glycol 8000 is a synthetic polymer made from ethylene oxide. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and add bulk to the medicine.
-
UNII WZH3C48M4T
Potassium hydroxide is a strong alkaline chemical used in medicines to adjust and maintain the pH level of liquid formulations, helping keep the product stable and the active ingredients effective.
-
UNII 6DC9Q167V3
Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
-
UNII 46N107B71O
Shellac is a natural resin secreted by the lac beetle. It's used as a coating on tablets and capsules to control how quickly the medicine dissolves and to improve appearance and stability.
-
UNII 368GB5141J
A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
-
UNII 7SEV7J4R1U
A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
-
UNII 15FIX9V2JP
Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
14 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · Q2 2026 | $0.2146 | $21.46 / 100 capsules |
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Venlafaxine Hydrochloride 37.5 mg 00093-7384-05 | Teva | 500 capsules | $0.079 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 37.5 mg 00904-7487-61 | Major | 1 capsule | $0.079 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 37.5 mg 42806-0601-09 | Epic | 90 capsules | $0.079 | AB | Availability likely | — |
| venlafaxine hydrochloride 37.5 mg 43598-0999-10 | Dr.Reddys | 1000 capsules | $0.079 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 37.5 mg 50268-0873-15 | AvPAK | 1 capsule | $0.079 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 37.5 mg 65862-0527-01 | Aurobindo | 100 capsules | $0.079 | — | Availability likely | — |
| Venlafaxine Hydrochloride 37.5 mg 68084-0698-01 | American | 1 capsule | $0.079 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 37.5 mg 70010-0184-03 | Granules | 30 capsules | $0.079 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 37.5 mg 70710-1698-00 | Zydus | 1000 capsules | $0.079 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 37.5 mg 82009-0056-10 | QUALLENT | 1000 capsules | $0.079 | AB | Availability likely | — |
| Venlafaxine hydrochloride 37.5 mg 33342-0194-07 | Macleods | 30 capsules | $0.100 | AB | FDA listed | — |
| Effexor XR 37.5 mg 58151-0125-77 | Viatris | 90 capsules | $17.704 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 37.5 mg 10135-0825-10 | Marlex | 1000 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 31722-0002-01 | Camber | 10 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 42291-0897-30 | AvKARE | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 46708-0792-30 | Alembic | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 50090-2281-00 | A-S | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 50090-5942-00 | A-S | 30 capsules | — | AB | FDA listed | — |
| venlafaxine hydrochloride 37.5 mg 50090-6301-00 | A-S | 1 capsule | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 50090-6834-00 | A-S | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 50090-7940-00 | A-S | 30 capsules | — | AB | FDA listed | — |
| venlafaxine hydrochloride 37.5 mg 55111-0453-01 | Dr.Reddy's | 100 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 60760-0836-30 | ST. | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 62332-0792-30 | Alembic | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 63187-0481-30 | Proficient | 30 capsules | — | AB | FDA listed | — |
| venlafaxine hydrochloride 37.5 mg 65841-0751-06 | Zydus | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 67046-0527-03 | Coupler | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 68071-2393-03 | NuCare | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 68071-3638-03 | NuCare | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 68071-5160-03 | NuCare | 30 capsules | — | AB | FDA listed | — |
| venlafaxine hydrochloride 37.5 mg 68382-0034-06 | Zydus | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 68788-7891-03 | Preferred | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 68788-7919-03 | Preferred | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 68788-8682-01 | Preferred | 100 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 70518-2532-00 | REMEDYREPACK | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 70518-3971-00 | REMEDYREPACK | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mgthis 70771-1836-04 | Zydus | 10 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 71205-0408-30 | Proficient | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 71205-0812-30 | Proficient | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 71335-1864-01 | Bryant | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 71335-2779-01 | Bryant | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 71335-9605-01 | Bryant | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 71335-9705-01 | Bryant | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 71785-1006-00 | Annora | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine HCL ER 37.5 mg 72189-0363-30 | Direct_Rx | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 72603-0747-01 | NorthStar | 90 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 72888-0179-30 | Advagen | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 76420-0630-01 | Asclemed | 100 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride ER 37.5 mg 80425-0290-01 | Advanced | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 80425-0476-01 | Advanced | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 80425-0581-01 | Advanced | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 37.5 mg 24658-0125-10 | PURACAP | 1000 capsules | — | AB | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2023
On the market since
May 2023
📍
2026
Currently FDA-listed
3 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for VENLAFAXINE HYDROCHLORIDE — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 70771-1836-00 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1836-0) | 2023-05-18 | Active |
| 70771-1836-03 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1836-3) | 2023-05-18 | Active |
| 70771-1836-04 You're viewing this | 10 BLISTER PACK in 1 CARTON (70771-1836-4) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70771-1836-2) | 2023-05-18 | Active |
| 70771-1836-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1836-5) | 2023-05-18 | Active |
| 70771-1836-09 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1836-9) | 2023-05-18 | Active |
Pack size FAQ
What quantity is in NDC 70771-1836-04?
NDC 70771-1836-04 is listed by the FDA — 10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack.
What NDC number is used to bill for this package of Venlafaxine Hydrochloride 37.5 mg Capsule, Extended Release?
Bill NDC 70771-1836-04 — the 11-digit billing format is 70771183604. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 70771-1836-4, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 70771-1836-04, written without dashes as 70771183604. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 70771-1836-04, the first segment (70771) is the labeler code FDA assigned to Zydus Lifesciences Limited; the middle segment (1836) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (04) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 30 capsules (70771-1836-03), 90 capsules (70771-1836-09), 500 capsules (70771-1836-05). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 Full prescribing information FDA SPL
The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label ▾
No readable label sections were found for this product.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.